R&D Strategy: Don’t Miss This Opportunity
NVIDIA and Eli Lilly have announced a new co-innovation lab for drug discovery, combining computational science and wet lab science. This partnership aims to revolutionize the drug discovery process by leveraging AI and robotics to inform experiments and model development in real-time.
NVIDIA and Eli Lilly have launched a co-innovation lab for drug discovery. The lab combines computational science and wet lab science to inform experiments and model development in real-time. This partnership aims to let scientists explore biological and chemical spaces digitally before creating a molecule. The goal is to reinvent how drug discovery happens. Other companies are also changing their approach to R&D, seeing it as a resource to anticipate future changes. Some R&D teams are struggling to adapt, while others see this moment as an opportunity to shape the future.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.